ChristinaHYeonMD

PubMed

• 2 citations
  Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancer.
  Sayeh M Lavasani, George Somlo, Susan E Yost, Paul H Frankel, Christopher Ruel, Yujie Cui, Mireya Murga, Aileen Tang, Norma Martinez, Laura Kruper, Lusine Tumyan, Dani...> ;Cancer. 2023 Mar 1
• 2 citations
  Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer.
  Xuan Ge, Susan E Yost, Jin Sun Lee, Paul H Frankel, Christopher Ruel, Yujie Cui, Mireya Murga, Aileen Tang, Norma Martinez, Samuel Chung, Christina Yeon, Daphne Stewar...> ;Cancers. 2022 Sep 1
• 4 citations
  A randomized trial of fulvestrant, everolimus and anastrozole for the front-line treatment of patients with advanced hormone receptor-positive breast cancer, SWOG S1222.
  Halle C. F. Moore, William E. Barlow, George Somlo, Julie R. Gralow, Anne F. Schott, Daniel F. Hayes, Peter Kuhn, James W. Hicks, Lisa Welter, Philip A. Dy, Christina ...> ;Clinical Cancer Research. 2021 Nov 29
• 33 citations
  Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer.
  Yuan Yuan, Jin Sun Lee, Susan E. Yost, Paul Frankel, Christopher Ruel, Colt Egelston, Weihua Guo, Simran Padam, Aileen Tang, Norma Martinez, Daniel Schmolze, Cary A. P...> ;European Journal of Cancer. 2021 Jul 1
• 22 citations
  Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer.
  Yuan Yuan, Jin Sun Lee, Susan E. Yost, Sierra Min Li, Paul Frankel, Christopher Ruel, Daniel Schmolze, Kim Robinson, Aileen Tang, Norma Martinez, Daphne Stewart, James...> ;The Oncologist. 2021 Mar 1
• 14 citations
  Integrating Academic and Community Cancer Care and Research through Multidisciplinary Oncology Pathways for Value-Based Care: A Review and the City of Hope Experience.
  Linda D. Bosserman, Mary Cianfrocca, Bertram Yuh, Christina Yeon, Helen Chen, Stephen Sentovich, Amy C. Polverini, Finly Zachariah, Debbie Deaville, Ashley Baker Lee, ...> ;Journal of Clinical Medicine. 2021 Jan 7
• 4 citations
  Use of HER2-Directed Therapy in Metastatic Breast Cancer and How Community Physicians Collaborate to Improve Care
  Joanne E. Mortimer, Laura Kruper, Mary Cianfrocca, Sayeh Moazami Lavasani, Sariah Liu, Niki Tank-Patel, Mina S. Sedrak, Wade Smith, Daphne Stewart, James Waisman, Chri...> ;Journal of Clinical Medicine. 2020 Jun 24
• 11 citations
  Strategies to improve participation of older adults in cancer research
  Jennifer Liu, Eutiquio Gutierrez, Abhay Tiwari, Simran Padam, Daneng Li, William Dale, Sumanta K. Pal, Daphne Stewart, Shanmugga Subbiah, Linda D. Bosserman, Cary A. P...> ;Journal of Clinical Medicine. 2020 May 22
• 14 citations
  A Phase II Trial of Older Adults With Metastatic Breast Cancer Receiving nab-Paclitaxel: Melding the Fields of Geriatrics and Oncology.
  Arti Hurria, Enrique Soto-Perez-de-Celis, Suzette Blanchard, Peggy Burhenn, Christina Yeon, Yuan Yuan, Daneng Li, Vani Katheria, J Waisman, Thehang H. Luu, G. Somlo, A...> ;Clinical Breast Cancer. 2019 Apr 1
• 17 citations
  Exploring characteristics, predictors, and consequences of fear of cancer recurrence among Asian-American breast cancer survivors.
  Kimlin Tam Ashing, Dalnim Cho, Lily L. Lai, Sophia Yeung, Lucy Young, Christina Yeon, Fong Yuman> ;Psycho-Oncology. 2017 Dec 1
• 7 citations
  Phase Ib Trial of mFOLFOX6 and Everolimus (NSC-733504) in Patients with Metastatic Gastroesophageal Adenocarcinoma.
  Vincent Chung, Paul Frankel, Dean Lim, Christina Yeon, Lucille Leong, Joseph Chao, Nora Ruel, Eloise Luevanos, Stephen Koehler, Samuel Chung, S. Cecilia Lau> ;Oncology. 2016 Apr 20
• Compliance (COMP) with colon cancer (CoC) national guidelines (NG) for chemotherapy (CT) by implementing electronic medical records (EMR).
  Ebrahimi B, Presant CA, Bosserman LD, Horns R, Vakil M, Upadhyaya G, Yeon C, Howard F, McNatt W, Emilio B> ;J. Clin. Oncol.. 2008-05-20
• 92 citations
  Aromatase Inhibitor–Associated Arthralgia and/or Bone Pain: Frequency and Characterization in Non–Clinical Trial Patients
  Cary A. Presant, Linda D. Bosserman, Traci Young, Mayank Vakil, Richard Horns, G. Upadhyaya, Behnam Ebrahimi, Christina Yeon, Frank Howard> ;Clinical Breast Cancer. 2007 Oct 1
• Aromatase inhibitor (AI)-associated arthralgia (A) and bone pain (BP): Frequency and characterization in clinical practice.
  Presant CA, Kelly C, Bosserman L, Upadhyaya G, Vakil M, Horns R, Ebrahimi B, Yeon C, Howard F, Rios A> ;J. Clin. Oncol.. 2006-06-20
• 72 citations
  Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer.
  Christina H Yeon, Mark D. Pegram> ;Investigational New Drugs. 2005 Oct 1
• Incidence of bevacizumab (BE) related toxicities: Association of hypertension (HTN) and proteinuria (PTN), a BE toxicity syndrome (BETS).
  Martel CL, Ebrahimi B, Horns RC, Upadhyaya GH, Vakil MJ, Yeon CH, Bosserman LD, Presant CA> ;J. Clin. Oncol.. 2005-06-01
• Increasing accrual (Ac) to clinical trials (CT) in community cancer clinics (CCC): A successful method using electronic medical records (EMR), virtual private network ...
  Vakil MJ, Bosserman LD, Presant CA, Martel CL, Ebrahimi B, Upadhyaya GH, Yeon CH, Scalia MD, Young T, Horns RC> ;J. Clin. Oncol.. 2005-06-01
• Development and implementation of effective quality (Q) guidelines (G) in community (com) cancer centers (CC): The cancer quality program (CQP).
  Bosserman LD, Presant CA, Vakil MJ, Horns RC, Upadhyaya G, Ebrahimi B, Martel CL, Yeon CH, Young T, Scalia MD> ;J. Clin. Oncol.. 2005-06-01
• 29 citations
  The p19INK4D cyclin dependent kinase inhibitor gene is altered in osteosarcoma.
  Carl W. Miller, C Yeon, A. Aslo, Susana Mendoza, Ugur Aytac, H P Koeffler> ;Oncogene. 1997 Jul 10
• Join now to see all